Family of Lyle and Erik Menendez told a judge Monday they want the men freed from the life sentences they are serving for the shotgun murders of their parents, as their court case suffered a delay. The pair have been in prison since a blockbuster trial in the 1990s that became almost compulsory viewing for millions of Americans. Television audiences were riveted by the gruesome details of the slayings of Jose and Kitty Menendez at the family's luxury Beverly Hills mansion. The two men, who have spent more than three decades behind bars, had been due to appear by videolink at a hearing in Los Angeles, their first court appearance in 28 years as a campaign to set them free gathers pace. But technical difficulties scuppered the appearance and the hearing was pushed back to the end of January. Nevertheless, Judge Michael Jesic called the two men's elderly aunts to the stand to hear them plead for the brothers to be freed. "I would like to be able to hug them and see them," Jose Menendez's older sister Terry Baralt, 85, said. "I would like them to come home." Kitty's sister, Joan Vander Molen, echoed that. "No child should go through what Erik and Lyle went through," she said. "They never knew if tonight will be the night when they would be raped." Prosecutors painted the crime as a cold-hearted bid by the then-young men -- Lyle was 21 and Erik was 18 -- to get their hands on their parents' $14 million fortune. But their attorneys described the 1989 killings as an act of desperate self-defense by young men subjected to years of sexual abuse and psychological violence at the hands of an abusive father and a complicit mother. The case saw a huge surge of renewed interest this year with the release of the Netflix hit "Monsters: The Lyle and Erik Menendez Story." The hearing comes after a campaign to secure their release, supported by Kim Kardashian and other celebrities. "Set them free before the Holidays!" wrote Tammi Menendez, Erik's wife, on social media last week. Public interest was such that the court held a lottery for the 16 seats in the public gallery. Nick Bonanno, a former high school classmate of Erik's, was the first to arrive at the court, taking his place at the head of the line at 4:30 am (1230 GMT). "I wanted to show support to... Eric and Lyle," he told AFP ahead of the hearing. "It's all about supporting and healing, not just for the families, but for us as a culture." Elena Gordon, 43, said she wanted "to witness a part of our local history." - 'It's really awesome' - The hearing was intended as a starting point for lawyers working on three routes to free Erik Menendez, 53, and Lyle Menendez, 56. Attorney Mark Geragos has filed a writ of habeas corpus, an attempt to effectively vacate the brothers' first-degree murder conviction, which could free the brothers immediately. Another route is an effort to get the men re-sentenced on the same conviction, which would open the way for them to request parole. Finally, Geragos has submitted a clemency request to California Governor Gavin Newsom. Journalist Robert Rand, who wrote a book about the case, and who is in regular touch with the brothers, said the family was optimistic. But, he said, no one was expecting any quick fixes. "They're hopeful," he said. "They don't know what's going to happen. "I believe this could take much longer than was originally anticipated. It could be six months, could be eight months, could be a year, but eventually they will get out." With excitement over the case near fever pitch, tourists are regularly making pilgrimages to the Beverly Hills home where the killings took place. Australian Christian Hannah, who was born almost two decades after the double murders, made sure the home was a stop on his tour of celebrity hotspots, because of his fascination with the Netflix show. "It's really awesome seeing it in person," he told AFP last week. "It's just because you see it on TV and you see it in person, just feels really cool." pr-hg/amz/jgcHave you bought ( )? There are plenty of reasons to consider buying Enbridge stock, and now is a great time to consider buying. Prospective investors considering investing in Enbridge stock can take solace in the following three reasons why Enbridge stock belongs in any portfolio. Enbridge is best known for its pipeline business, and for good reason. The segment, which includes both natural gas and crude elements, is the largest and most complex pipeline system on the planet. That network hauls massive amounts each day. Approximately 5.8 million barrels of oil and 24.6 Bcf/d (billions of cubic feet per date) of gas. To put that insane amount another way, Enbridge transports nearly one-third of all North American-produced crude and one-fifth of the natural gas needs of the U.S. In other words, Enbridge is one of the most defensive options on the market. That alone is reason enough to buy Enbridge stock, but there’s still plenty more to note. Apart from its core pipeline business, Enbridge also boasts several other segments. This includes a natural gas utility and a growing renewable energy business. The business comprises 38 facilities located across North America and Europe. The sites include solar, wind, and hydro elements, which generate a stable revenue stream that is subject to the same regulated model that utilities follow. Enbridge has dropped more than $10 billion into the segment in the past two decades to build out a renewable net generating capacity of 3,481 megawatts. That’s enough to meet the power needs of nearly 1.3 million homes. Turning to the natural gas business, Enbridge’s gas utility serves seven million customers with over 100,000 km of service lines across North America. Both segments operate like utilities, generating recurring and stable revenue streams that allow the company to invest in growth initiatives and pay out a handsome . That level of diversification provides a solid reason for prospective investors to consider buying Enbridge stock. One of the main reasons why investors turn to Enbridge stock is its lucrative quarterly dividend. As of the time of writing, the yield on that dividend works out to an impressive 6.14%. Not only does that mean that Enbridge is one of the best-paying dividends on the market, but also that it can provide growth, too. That’s because investors who aren’t ready to draw on that income yet can choose to reinvest it until needed. This allows any eventual income to grow over time thanks to reinvested dividends. Speaking of income growth, another key point to note is that Enbridge has provided annual upticks to that dividend for three decades without fail. That fact alone makes Enbridge stock a must-have addition to any portfolio. There’s no shortage of great stocks on the market, but few can provide the growth and income-earning potential that Enbridge can. Additionally, Enbridge’s defensive appeal for longer-term investors shouldn’t be ignored. In my opinion, Enbridge stock is a must-have option that should be a core holding in any .Meet to focus on Chiang Mai flood recovery

(The Center Square) – A political insider says the nature of Illinois politics has dramatically changed in the past two decades. Although Democrats won a majority of seats statewide, Republicans made some strides. President-elect Donald Trump won a larger percentage of the Illinois vote than he did four years ago. “The voters that were for Trump were concerned about inflation, the economy, immigration, and a judgment on the Biden Administration,” said Kent Redfield, professor of political science at the University of Illinois-Springfield during a University of Illinois-Extension webinar. “People were not pleased with the direction of the country.” During a recent news conference, Illinois House Republicans said they believe voters sent Democrats a message at the ballot box, and it’s time to change. “The residents of the state voted with their pocket books in mind. signaling a resounding call for better fiscal accountability and immediate relief,” said House Minority Leader Tony McCombie, R-Savanna. Redfield said Illinois Democrats have created a super majority simply by drawing legislative maps in their favor. “Democrats in drawing the maps have taken what is an advantage in terms of demographics and voting behaviors,” said Redfield. A report card from the Coalition Hub for Advancing Redistricting and Grassroots Engagement gave Illinois an “F” grade due to “egregious racial and partisan gerrymandering, or sorting voters based on race and partisanship.” Redfield said downstate Illinois continues to be mostly Republican, but the political scene is different now. “Dramatically within Illinois, we’ve gone from a party-centered kind of process to one that is much more candidate-centered,” said Redfield.

Solar D banks on robotic panel installer

OSAKA, Japan and MONTREAL , Dec. 5, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan ; President: Toichi Takino; "Ono") announced that it has entered into a drug discovery collaboration agreement with Congruence Therapeutics (Headquarters: Montreal, Quebec, Canada ; CEO: Clarissa Desjardins; "Congruence") to generate novel small molecule correctors against multiple protein targets in the oncology area by leveraging Congruence's proprietary drug discovery platform, RevenirTM. Under the terms of the agreement, Congruence will generate small molecule correctors by leveraging Congruence's proprietary drug discovery engine called, RevenirTM. Ono will obtain an exclusive option right to develop, manufacture and commercialize the identified small molecule correctors worldwide. Congruence will be eligible to receive an upfront payment, research expenses, milestone payments based on research and development progress and sales, as well as tiered royalties based on net sales. "We believe that this collaboration with Congruence may help generating novel small molecule correctors for validated targets in the oncology area by leveraging their own technologies in protein dynamics and computational biology, leading to our development pipeline," said Seishi Katsumata , Corporate Officer / Executive Director, Discovery & Research of Ono. "We will be committed to delivering innovative new drugs to cancer patients as soon as possible." "Congruence is thrilled to partner with Ono, which has established itself as a global leader in drug development, particularly in the oncology space. We believe that our RevenirTM platform and capabilities in protein dynamics will accelerate the discovery of novel therapies for compelling targets of interest to both companies," said Sharath Hegde PhD, Chief Scientific Officer of Congruence. About RevenirTM Drug Discovery Platform RevenirTM, Congruence's proprietary computational drug discovery platform, captures the dynamic biophysical changes caused by mutations in proteins, offering unique insights into protein defects and their correction. By examining surface features and a spectrum of biophysical descriptors across an ensemble of protein conformers, RevenirTM predicts small molecule induced correction of the underlying defect. About Congruence Therapeutics Congruence is a computationally-driven biotechnology company building a unique pipeline of transformative small molecule correctors rationally designed to rescue aberrant protein function. Congruence's proprietary scalable platform, RevenirTM, captures the biophysical features of proteins across their conformational ensembles, in order to identify novel allosteric and cryptic pockets which are virtually screened to generate novel chemical matter. For more information, please visit www.congruencetx.com . View original content to download multimedia: https://www.prnewswire.com/news-releases/ono-enters-into-drug-discovery-collaboration-agreement-with-congruence-therapeutics-to-generate-novel-small-molecule-correctors-in-the-oncology-area-302324452.html SOURCE Ono Pharmaceutical co., ltd.SAN FRANCISCO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) and certain of its most senior executives are now entangled in a securities class action, alleging the company deceived investors by making false and misleading statements about its advanced nuclear fuel technologies. Hagens Berman urges investors in ASP Isotopes who suffered substantial losses to submit your losses now . Class Period: Oct. 30, 2024 – Nov. 26, 2024 Lead Plaintiff Deadline: Feb. 3, 2025 Visit: www.hbsslaw.com/investor-fraud/aspi Contact the Firm Now: ASPI@hbsslaw.com 844-916-0895 ASP Isotopes Inc. (ASPI) Securities Class Action: The suit, filed in the United States District Court for the Southern District of New York, claims that ASPI misled investors about the viability and potential of its Aerodynamic Separation Process (ASP) and Quantum Enrichment technologies. The complaint alleges that ASPI overstated the effectiveness of its enrichment technologies, the development potential of its high assay low-enriched uranium facility, and the performance of its nuclear fuels operating segment. The truth emerged on Nov. 26, 2024, when a scathing report by Fuzzy Panda Research revealed that ASPI's technology was outdated and unlikely to be commercially viable. The report accused ASPI of using "old, disregarded laser enrichment technology" to falsely position itself as a cutting-edge nuclear fuel company. It also alleged that ASPI had employed individuals to promote its stock and that former executives of Centrus Energy had deemed its technology "virtually worthless.". Following the release of the report, ASPI's stock price plummeted 23% in a single trading day. These events have prompted shareholder rights firm Hagens Berman to open a probe. “We are investigating whether ASPI may have misled investors about the true commercial prospects for its ASP and Quantum Enrichment technologies," said Reed Kathrein, a partner leading the investigation. If you invested in ASP Isotopes or have knowledge that may assist the firm’s investigation, submit your losses now » If you’d like more information and answers to frequently asked questions about the ASP Isotopes case and our investigation, read more » Whistleblowers: Persons with non-public information regarding ASP Isotopes should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email ASPI@hbsslaw.com . About Hagens Berman Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com . Follow the firm for updates and news at @ClassActionLaw . Contact: Reed Kathrein, 844-916-0895

NoneWhy Bugatti, Czinger, and Other Marques Are 3-D Printing Their HypercarsNIST Seeks Public Input on Zero Trust Guidance

The Kimball High and Tracy High boys basketball teams delivered an early season classic when they squared off in their campaign curtain raiser at Kimball last Friday night. The two teams were evenly matched and as such, their back and forth went right down to the wire. In the final moments, you could have cut the tension inside the gym with a butter knife. With the game tied at 55-55 and under three seconds remaining in the fourth quarter, the deadlock was broken by Tracy junior Juan Godoy who bottomed a buzzer beater to give the ‘Dogs a statement 57-55 win. Godoy was found cutting towards the paint by a sharp entry pass from senior Jaden Martinez on the wing. The former rose up immediately and floated a contested shot into the basket – sending the packed Tracy side of the bleachers into a frenzy with the celebrations spilling out onto the court. “It was a tough game,” Bulldogs’ head coach Junior Cueva said afterwards. “We were without three guards and two of our other ball handlers fouled out. It was great to see our bench and role players close it out. The team executed perfectly down the stretch.” Martinez poured in 10 points and added three rebounds for the visitors. Tracy was led by senior Ahmad Hardman with 12 points and eight boards. The Jaguars battled admirably and shared the wealth on offense among four players in their debut outing under first year head coach Ben Juarez. Football stars senior Jaylin Rodgers (8) and senior Tobe Nwankwo (11) combined for 19 points. Nwankwo led the hosts in scoring and added three boards and two steals. Rodgers pulled in 10 rebounds. Sophomore Rehmat Mann and junior Tristen DeBenedetti chipped in with nine points apiece. The Bulldogs have since improved to 2-0 on the year after mauling Millennium 83-29 in their home opener on Monday night. The Falcons are 0-2. They lost their first game to Valley (Sacramento) 53-29 last Tuesday. Contact Arion Armeniakos at aarmeniakos@tracypress.com , or call 209-830-4229.A late-game rally derailed by a missed extra point and Cowboys stun Commanders 34-26Amazon just dropped tons of early Black Friday deals over 50% off: here's what to get before they sell out